Benign gynecologic conditions associated with a CA-125 Level >1,000 U/mL: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 3, 1996, Pages 179-182

  Kammerer Doak, Dorothy N ^b   Magrina, Javier E ^a   Nemiro, Jay S ^b   Lidner, Thomas K ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

Adenomyosis; CA 125 antigen; Endometriosis

Indexed keywords

CA 125 ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOMETRIOSIS; FEMALE; HUMAN; OVARY CANCER; OVARY INSUFFICIENCY; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; ENDOMETRIOSIS; FEMALE; FERTILIZATION IN VITRO; GONADAL STEROID HORMONES; HUMANS; OVARIAN FAILURE, PREMATURE; UTERINE DISEASES;

EID: 0029960801     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Barbieri RL, Niloff JM, Bast RC Jr, et al: Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986;45:630-634
2. Bast RC Jr, Feeney M, Lazarus H, et al: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981;68:1331-1337
3. Bast RC Jr, Klug TL, St John E, et al: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983;309:883-887
4. Brumsted JR, Nakajima ST, Badger G, et al: Serum concentration of CA-125 during the first trimester of normal and abnormal pregnancies. J Reprod Med 1990;35:499-502
5. Cancer Facts and Figures 1993. Atlanta, American Cancer Society, 1993
6. Check JH, Coates TE, Nowroozi K: Extreme elevation of se-rum CA-125 in two women with severe endometriosis: Case report. Gynecol Endocrinol 1991;5:217-220
7. Check JH, Nowroozi K, Vaze M, et al: Very high CA 125 levels during early first trimester in three cases of spontaneous abortion with chromosomal abnormalities. Am J Obstet Gynecol 1990;162:674-675
8. Check JH, Nowroozi K, Winkel CA, et al: Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion. Obstet Gynecol 1990;75:742-744
9. Daoud E, Bodor G: CA-125 concentrations in malignant and nonmalignant disease. Clin Chem 1991;37:1968-1974
10. Einhorn N, Bast RC Jr, Knapp RC, et al: Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Obstet Gynecol 1986;67:414-416
11. Giudice LC, Jacobs A, Pineda J, et al: Serum levels of CA-125 in patients with endometriosis: A preliminary report. Fertil Steril 1986;45:876-878
12. Lanzone A, Marana R, Muscatcllo R, et al: Serum CA-125 levels in the diagnosis and management of endometriosis. J Reprod Med 1991;36:603-607
13. Malkasian G Jr, Knapp RC, Lavin PT, et al: Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease. Am J Obstet Gynecol 1988;159:341-346
14. Nagata H, Takahashi K, Yamane Y, et al: Abnormally high values of CA 125 and CA 19-9 in women with benign tumors. Cynecol Obstet Invest 1989;28:165-168
15. Pittaway DE, Payez JA: The use of CA-125 in the diagnosis and management of endometriosis. Fertil Steril 1986;46:790-795
16. Seki K, Kikuchi Y, Uesato T, et al: Increased scrum CA 125 levels during the first trimester of pregnancy. Acta Obstet Gynecol Scand 1986;65:583-585
17. Soper JT, Hunter VJ, Daly L, et al: Preoperative serum tumor-associated antigen levels in women with pelvic masses. Obstet Gynecol 1990;75:249-254
18. Takahashi K, Kijima S, Yoshino K, et al: Serum CA 125 as a marker for patients with external endometriosis. Int J Fertil 1989;34:143-148